NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$23.41
+$0.83 (+3.68%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 424.15M | 457.61M | 490M | 538.41M | 563.86M | 748.42M | 771.74M | 422.73M | 430.71M | 481.15M | 340.45M | 418.66M | 467.73M | 467.73M | 93.74M | 712.16K | 60.38M | 635.59K | 789.5K | 1.16M |
Short-Term Investments | 209.7M | 178.5M | 146.24M | 164.54M | 175.3M | 60.06M | 62.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 44.41M | n/a | n/a | 53.09M | 44.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 124.74M | n/a | 138.01M | 138.01M | 138.01M |
Other Long-Term Assets | n/a | 73.82M | 92.61M | n/a | n/a | n/a | n/a | n/a | 8K | 16K | 35K | 89.22M | 156K | 156K | 762.7K | 805.4K | 816.56K | n/a | n/a | n/a |
Receivables | 24M | 8.22M | 23.15M | 20.25M | n/a | 1.61M | 21.31M | 5.15M | n/a | n/a | n/a | n/a | n/a | n/a | 120.48M | 127.23M | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.36M | 1.34M | 1.32M | 1.31M | 19.75M | n/a | n/a | n/a | 5.41M | 4.13M | 1.88M | n/a | 2.07M | 2.07M | 1.66M | 217.76K | 4.88M | n/a | n/a | n/a |
Total Current Assets | 659.21M | 658.04M | 675.7M | 732.33M | 769.85M | 817.3M | 863.41M | 437.87M | 445.35M | 487.82M | 346.79M | 424.96M | 477.98M | 477.98M | 227.29M | 929.92K | 66.96M | 966.42K | 1.21M | 1.64M |
Property-Plant & Equipment | 493K | 400K | 568K | 569K | 620K | 607K | 673K | 724K | 788K | 139K | 101K | 122.27K | 154K | 154K | 183.34K | 193.61K | 216.08K | 220.06K | n/a | n/a |
Goodwill & Intangibles | 343K | 375K | 407K | 439K | 470K | 502K | 534K | 593K | 542K | 486K | 170K | n/a | 208K | 208K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 45.25M | 74.6M | 93.58M | 54.1M | 45.26M | 1.11M | 1.21M | 1.32M | 1.34M | 641K | 306K | 89.34M | 518K | 518K | 946.05K | 124.74M | 1.03M | 138.01M | 138.01M | 138.01M |
Total Assets | 704.45M | 732.64M | 769.28M | 786.43M | 815.11M | 818.41M | 864.62M | 439.19M | 446.69M | 488.46M | 347.1M | 514.3M | 478.5M | 478.5M | 228.24M | 125.67M | 67.99M | 138.98M | 139.22M | 139.64M |
Account Payables | 5.42M | 8.09M | 8.97M | 3.63M | 5.9M | 6.09M | 4.74M | 7.04M | 5.28M | 8.54M | 16.92M | 22.77M | 11.85M | 11.85M | 12.34M | 13.03M | 7.07M | 7.2M | n/a | n/a |
Deferred Revenue | 2.8M | 3.99M | 3.99M | n/a | n/a | 3.03M | 6.01M | 4.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 23K | 136K | 181K | n/a | 252K | 246K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.4K | 1.09K | n/a |
Other Current Liabilities | 54.45M | 55.32M | 72.69M | 48.59M | 20.93M | 29.58M | 91.03M | 29.48M | 29.6M | 41.18M | 21.52M | 19.01M | 18.02M | 18.02M | 14.73M | 97.28K | 519.69K | 243.48K | 116.46K | 243.34K |
Total Current Liabilities | 72.97M | 67.42M | 85.79M | 58.27M | 36.51M | 40.91M | 106.92M | 41.26M | 45.31M | 59.73M | 49.9M | 41.85M | 36.06M | 36.06M | 27.14M | 97.28K | 11.24M | 245.88K | 117.54K | 243.34K |
Long-Term Debt | n/a | n/a | 66K | 85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.81M | 13.62M | 16.93M | 8.81M | 11.44M | 12.31M | 12.31M | 7.79M | 5.36M | n/a | 8.02M | 10.12M | 9.12M |
Total Long-Term Liabilities | 56K | n/a | 66K | 85K | 103K | 137K | 202K | 19.07M | 13.94M | 16.93M | 8.81M | 11.46M | 12.37M | 12.37M | 7.89M | 5.36M | 126.24K | 8.02M | 10.12M | 9.12M |
Total Liabilities | 73.03M | 67.42M | 85.85M | 58.36M | 36.62M | 41.05M | 107.12M | 60.33M | 59.25M | 76.66M | 58.7M | 53.31M | 48.43M | 48.43M | 35.03M | 5.45M | 11.36M | 8.27M | 10.24M | 9.36M |
Total Debt | 82K | 23K | 202K | 266K | 328K | 389K | 448K | 506K | 562K | 43K | 60K | 94.98K | 126K | 126K | 158.2K | 167.05K | 186.51K | 2.4K | 1.09K | n/a |
Book Value | 631.42M | 665.22M | 683.43M | 728.07M | 778.5M | 777.36M | 757.5M | 378.86M | 387.44M | 411.8M | 288.39M | 460.99M | 430.07M | 430.07M | 193.21M | 120.22M | 56.63M | 130.71M | 128.98M | 130.28M |
Book Value Per Share | 5.12 | 5.49 | 5.97 | 6.12 | 6.92 | 6.69 | 7.81 | 4 | 4.09 | 5.01 | 3.50 | 5.59 | 5.25 | 5.27 | 10.52 | 6.77 | 3.19 | 7.36 | 7.27 | 7.34 |
Common Stock | 14.74M | 14.59M | 14.28M | 14.11M | 14.01M | 13.97M | 13.44M | 11.44M | 11.15M | 11.11M | 10.17M | 10.78M | 10.06M | 10.06M | 178.1K | 124.71M | 128.51K | 138M | 123.98M | 125.28M |
Retained Earnings | -874.97M | -810.83M | -762.39M | -687.47M | -615.46M | -598.1M | -558.57M | -466.39M | -449.75M | -410.74M | -316.97M | -212.3M | -140.04M | -140.04M | 20.78M | -4.5M | -39.44M | -7.29M | 1.56M | 2.86M |
Comprehensive Income | 3.86M | 4.22M | 4.79M | 4.64M | 4.33M | 4.43M | 4.47M | 4.42M | 4.42M | 4.42M | 4.42M | 8.7M | 4.42M | 4.42M | 1.08M | 1.14M | 672.13K | 684.5K | n/a | -4.19M |
Shareholders Equity | 631.42M | 665.22M | 683.43M | 728.07M | 778.5M | 777.36M | 757.5M | 378.86M | 387.44M | 411.8M | 288.39M | 460.99M | 430.07M | 430.07M | 193.21M | 120.22M | 56.63M | 130.71M | 128.98M | 130.28M |
Total Investments | 254.11M | 178.5M | 146.24M | 217.63M | 219.47M | 60.06M | 62.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 124.74M | n/a | 138.01M | 138.01M | 138.01M |
Add to Watchlist
Select watchlists to add or remove NAMS